Abstract
Otolaryngology–Head and Neck SurgeryVolume 129, Issue 2 p. P192-P193 Wednesday, September 24, 2003: 8:00 am to 9:30 am: Room OCCC 205: Scientific Sessions: Otology/Neurotology 8:16 AM: Results of a Randomized, Placebo-Controlled Clinical Trial of Famvir for Active Meniere's Disease M Jennifer Derebery presenter MD, M Jennifer Derebery presenter MD Los Angeles, CASearch for more papers by this authorLaurel M Fisher PhD, Laurel M Fisher PhD Los Angeles, CASearch for more papers by this authorAnn Masuda MS, Ann Masuda MS Los Angeles, CASearch for more papers by this author M Jennifer Derebery presenter MD, M Jennifer Derebery presenter MD Los Angeles, CASearch for more papers by this authorLaurel M Fisher PhD, Laurel M Fisher PhD Los Angeles, CASearch for more papers by this authorAnn Masuda MS, Ann Masuda MS Los Angeles, CASearch for more papers by this author First published: 17 May 2016 https://doi.org/10.1016/S0194-59980301223-3Read the full textAboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume129, Issue2August 2003Pages P192-P193 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
